Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-09-11-Speech-2-366-375"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-09-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:Explanations of vote2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20120911.32.2-366-375"2
lpv:hasSubsequent	lp_eu:2012-09-11-Speech-2-366-5002
lpv:speaker	lp:Jean-Luc Bennahmias2
lpv:spokenAs	unknown; Mouvement Démocrate (2009-07-14--2014-06-30)3 substitute; Delegation for relations with the United States (2009-09-16--2014-06-30)3 substitute; REGI (2012-01-19--2012-11-04)3 substitute; Delegation for relations with Australia and New Zealand (2012-02-13--2014-06-30)3 member; EMPL (2012-01-19--2014-06-30)3 member; ALDE (2009-07-14--2014-06-30)3
lpv:translated text	"Whilst the Mediator affair has revealed severe shortcomings in the area of medicine safety, I welcome the agreement that we have ratified today at first reading. This pharmacovigilance package meets an additional safety requirement. This requires an amendment to the 2001 directive to reinforce the legal framework: to create an automatic urgent procedure, to increase the transparency obligations for companies and to provide for a blacklist of medicines subject to additional surveillance. These are the new features of this reform which, we hope, will be able to make up for the shortcomings and boost the reliability of the European medicine system."@en1

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph